Suspension of trading

Valuation eFFECTOR Therapeutics, Inc. Deutsche Boerse AG

Stocks

Market Closed - Deutsche Boerse AG 11:59:01 24/06/2024 +04			5-day change	1st Jan Change
1.075 ^EUR	+0.47%		-8.12%	-88.97%

11/09/24	Tyra Biosciences Names Doug Warner Chief Medical Officer	MT
08/07/24	EFFECTOR Therapeutics, Inc.(OTCPK:EFTR) dropped from S&P TMI Index	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023
Market Cap ¹	334.3	17.91	30.2
Change	-	-94.64%	68.61%
Enterprise Value (EV) ¹	304.6	11.88	32.38
Change	-	-96.1%	172.45%
P/E	18.8x	-0.78x	-0.71x
PBR	19.3x	4.58x	-6.01x
PEG	0x	0x	-0x
Capitalization / Revenue	233,760,757x	5,041,796x	-
EV / Revenue	-	-	-
EV / EBITDA	-9.56x	-0.37x	-0.96x
EV / EBIT	-9.55x	-0.37x	-0.96x
EV / FCF	-	-	-
FCF Yield	-	-	-
Dividend per Share ²	-	-	-
Rate of return	-	-	-
EPS ²	11	-13.76	-16.37
Distribution rate	-	-	-
Net sales	1.43	3.553	-
EBITDA ¹	-31.87	-32.35	-33.73
EBIT ¹	-31.9	-32.4	-33.84
Net income ¹	15.8	-22.66	-35.81
Net Debt ¹	-29.67	-6.029	2.175
Reference price ²	207.000000	10.690000	11.685000
Nbr of stocks (in thousands)	1,615	1,676	2,585
Announcement Date	16/03/22	08/03/23	26/03/24

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
WUXI APPTEC CO., LTD.	20.78x	7.37x	14.79x	1.43%	70.88B
ARGENX SE	32.47x	9.38x	45.35x	0.04%	62.49B
INSMED INCORPORATED	-73.25x	14.16x	-68.28x	-.--%	26.21B
WUXI BIOLOGICS (CAYMAN) INC.	30.44x	6.47x	16.8x	-.--%	26.34B
BIONTECH SE	-14.7x	5.35x	-6.73x	-.--%	24.13B
GENMAB A/S	28.25x	5.33x	17.72x	-.--%	20.72B
PHARMAESSENTIA CORPORATION	44.51x	16.33x	33.12x	0.34%	15.36B
EXELIXIS, INC.	18.03x	5.37x	12.55x	-.--%	14.46B
SUMMIT THERAPEUTICS INC.	-15.41x	3483.86x	-17.81x	-.--%	14.25B
Average	7.90x	394.85x	5.28x	0.2%	30.54B
Weighted average by Cap.	12.15x	188.68x	11.56x	0.4%